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What does the BJD now stand for? 
A position statement 
This issue of the BJD includes a position statement concern-
ing the BJD, and an explanatory editorial. So what does the 
BJD stand for in 2015? Four key themes are identified: clini-
cal trials, epidemiology, qualitative research and translation-
al research. The editorial explains that the BJD is a clinical 
journal, with readership around the world of clinical der-
matologists. The position statement is anchored on improv-
ing patient care as the focus of the journal’s endeavours. The 
position statement is as follows: the BJD aims to publish the 
highest quality research encompassing the following:
(i) Clinical trials that are registered before recruitment 
starts and that report fully according to the CONSORT guide-
lines,
(ii) Clinical studies that include epidemiology, qualitative 
research and mixed methods that conform to the STROBE 
guidelines, and
(iii) Translational research that describes basic and 
applied science of potential clinical relevance.
The editorial concludes by explaining that each element of 
the statement will be explored in more detail in editorials to 
be published in the BJD in coming months. The authors fin-
ish by stating that the position statement has been created in 
order to sharpen the BJD’s focus on high-quality research for 
clinical dermatologists worldwide as they strive to provide 
the highest quality patient care. Br J Dermatol 2015; 172: 
doi:10.1111/bjd.13855.
‘We’re all carrying a burden that we’re not 
sharing’: a qualitative study of the impact 
of cutaneous T-cell lymphoma on the 
family 
The authors from King’s College and St John’s Institute of 
Dermatology, London start by explaining that cutaneous 
T-cell lymphoma (CTCL) is a rare, progressive cancer that can 
be life limiting and highly disfiguring. They state that CTCL 
has a negative impact on patients’ quality of life and set out 
to explore and define this through in-depth, face-to-face, 
semistructured qualitative interviews conducted with current 
caregivers of patients with CTCL (either Sézary syndrome or 
mycosis fungoides). Fourteen carers participated (age range 
39–85 years), 11 of whom were spouses, one a friend and 
two daughters. All were white British and four were men. 
The authors report that family caregivers of patients with 
CTCL experience multiple demands from the disease and 
the burden of caregiving. They conclude from this research 
study that CTCL has a profound impact on family dynamics 
and relationships and that support services for families are 
 needed that provide tailored information and are able to 
understand family adjustment processes. Br J Dermatol 2015; 
172: 1581–92.
Psoriasis and obesity in French children: a 
case–control, multicentre study
The authors from France state that obesity is more frequent 
in adults with psoriasis than in the general population. They 
then point out that few data are available on obesity in chil-
dren with psoriasis. In order to investigate a putative link, they 
carried out a multicentre case–control study in 23 French 
dermatology centres. Comorbidities in children and parents 
were routinely collected. They used children without chronic 
or genetic inflammatory disease as controls, having matched 
them for age, sex and dermatology centre. Three weight cut-
offs were used to compare the two groups: overweight, over-
weight with abdominal obesity, and overweight with obesity, 
according to the French Health Authority guidelines. In total 
261 children with psoriasis and controls were included. Their 
mean age was 9.8 years, 126 were male and 135 female, 
42.5% had plaque psoriasis and 32.2% had severe psoriasis. 
When comparing the frequency of overweight children, there 
was no difference between the two groups (20.7% in the pso-
riasis group vs. 17.1% in control group; P = 0.18). The only 
determinants for overweight or obesity in the psoriasis group 
were female sex, or having a parent who was also overweight 
(also found in controls). The authors concluded that over-
weight with abdominal obesity and obesity were more fre-
quent in children with psoriasis than in controls. Risk factors 
identified were female sex and the presence of an overweight 
parent, which are similar to those seen in the French general 
population. However, the severity and clinical type of pso-
riasis were not associated with children being overweight or 
having obesity. Br J Dermatol 2015; 172: 1593–1600.
